Memantine and blood urea increased Patient Reports February 12, 2012

Memantine Side Effects Report #5724389-6
Memantine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 11, 2008. Male patient, 75 years of age, was diagnosed with parkinson's disease  and was treated with Memantine. After drug was administered, patient experienced the following side effects: asthenia, blood urea increased, electrocardiogram abnormal, feeling hot, flushing, glomerular filtration rate decreased, paraesthesia, sensory disturbance, sinus bradycardia. Memantine dosage: unknown. During the same period patient was treated with SINEMENT, ATENOLOL, LISINOPRIL, ACETAMINOPHEN W, STALEVO. Patient recovered.

Memantine Side Effects Report #5135621-4
Memantine side effect was reported by a Physician from UNITED STATES on Oct 16, 2006. Female patient, 86 years of age, weighting 130.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood calcium decreased, blood chloride increased, blood glucose increased, blood potassium decreased, blood sodium increased, blood urea increased, diarrhoea haemorrhagic, diverticulitis. Memantine dosage: 28 MG QD PO. During the same period patient was treated with IMODIUM. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5025456-5
Memantine side effect was reported by a Physician from UNITED STATES on June 06, 2006. Female patient, 86 years of age, weighting 130.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood calcium decreased, blood potassium decreased, blood sodium increased, blood urea increased, diarrhoea haemorrhagic, diverticulitis intestinal haemorrhagic, leukocytosis, lymphocyte count increased. Memantine dosage: 28 MG QD PO. During the same period patient was treated with IMODIUM, FLAGYL, PROTONIX, CIPROFLOXACIN. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5039830-4
Memantine side effect was reported by a Physician from UNITED STATES on June 13, 2006. Female patient, 86 years of age, weighting 130.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood calcium decreased, blood chloride increased, blood glucose increased, blood potassium decreased, blood sodium increased, blood urea increased, csf white blood cell count increased, diverticulitis intestinal haemorrhagic, leukocytosis. Memantine dosage: 28 MG QD PO. During the same period patient was treated with IMODIUM. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #5648751-5
Memantine side effect was reported by a Physician from CHILE on Feb 25, 2008. Male patient, 85 years of age, weighting 202.8 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: accident, acute myocardial infarction, atrioventricular block, blood urea increased, bundle branch block left, fall , hip fracture, ventricular arrhythmia. Memantine dosage: 28 MG QD PO. During the same period patient was treated with CHLORODIAZEPOXIDE, DONEPEZIL, ENALAPRILE, ASPIRIN. Patient was hospitalized. Patient died on 09/27/2007.

Memantine Side Effects Report #5575721-8
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on Dec 11, 2007. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood cholinesterase decreased, blood creatinine increased, blood glucose increased, blood urea increased, c-reactive protein increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with DONEPEZIL, PROPIVERINE, ANTIBIOTIC, MAGNESIUM OXIDE, TRIMEBUTINE, GLYBURIDE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5692109-X
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Mar 18, 2008. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood cholinesterase decreased, blood creatinine increased, blood glucose increased, blood urea increased, cholecystitis. Memantine dosage: 20 MG QD PO. During the same period patient was treated with DONEPEZIL, PROPIVERINE, ANTIBIOTIC, MAGNESIUM OXIDE, TRIMEBUTINE, GLYBURIDE. Patient was hospitalized. Patient died on 01/19/2008.

Memantine Side Effects Report #5832246-X
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on July 22, 2008. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood glucose increased, blood urea increased, carbohydrate antigen 19-9 increased, cholecystitis, cholelithiasis, enteritis infectious, femoral neck fracture, pneumonia , pneumonia aspiration. Memantine dosage: 20 MG (20 MG,1 IN 1 D), ORAL. During the same period patient was treated with DONEPEZIL HYDROCHLORIDE, PROPIVERINE, ANTIBIOTIC, MAGNESIUM OXIDE, TRIMEBUTINE, GLYBURIDE. Patient was hospitalized. Patient died on 01/19/2008.

Memantine Side Effects Report #4587149-8
Memantine side effect was reported by a Health Professional from on Feb 01, 2005. Male patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, atrial fibrillation , blood chloride increased, blood glucose increased, blood potassium decreased, blood urea increased, bundle branch block left, cardiomegaly, coronary artery atherosclerosis. Memantine dosage: 20 MG QD PO. During the same period patient was treated with FUROSEMIDE, POTASSIUM CHLORIDE, ZOLPIDEM TARTRATE, ERTHROMYCIN. Patient was hospitalized. Patient died on 11/11/2004.


Memantine Side Effects Report #4609121-1
Memantine side effect was reported by a Physician from on Mar 07, 2005. Male patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, blood chloride increased, blood glucose increased, blood sodium increased, blood urea increased, bundle branch block left, cardiomegaly, coronary artery atherosclerosis. Memantine dosage: 20 MG QD PO. During the same period patient was treated with FUROSEMIDE, POTASSIUM CHLORIDE, ZOLPIDEM TARTRATE, ERTHROMYCIN. Patient was hospitalized. Patient died on 11/11/2004.

Memantine Side Effects Report #4662961-5
Memantine side effect was reported by a Health Professional from on May 02, 2005. Male patient, 83 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood glucose increased, blood triglycerides increased, blood urea increased, glycosylated haemoglobin increased, renal function test abnormal. Memantine dosage: 15 MG QD PO. During the same period patient was treated with AQUAPHORIL, SERMION, SEROQUEL, AMARYL, XEFO, THROMBO ASS, FAMOTIDIN. Patient recovered.

Memantine Side Effects Report #4673070-3
Memantine side effect was reported by a Health Professional from on May 18, 2005. Male patient, 83 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood glucose increased, blood triglycerides increased, blood urea increased, glycosylated haemoglobin increased. Memantine dosage: 15 MG QD PO. During the same period patient was treated with AQUAPHORIL, SERMION, SEROQUEL, AMARYL, XEFO, THROMBO ASS, FAMOTIDIN. Patient recovered.

Memantine Side Effects Report #5736300-2
Memantine side effect was reported by a Consumer or non-health professional from FRANCE on Apr 22, 2008. Female patient, 82 years of age, was diagnosed with dementia alzheimer's type, hypertension, urinary incontinence  and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood glucose increased, blood urea increased, bradycardia, loss of consciousness, malaise, orthostatic hypotension. Memantine dosage: 10 MG BID PO. During the same period patient was treated with MODUCREN, ARICEPT, TANAKAN, LANSOPRAZOLE, DITROPAN. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #4758423-7
Memantine side effect was reported by a Health Professional from FRANCE on Aug 12, 2005. Female patient, 81 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, blood creatinine increased, blood thyroid stimulating hormone increased, blood urea increased, chlamydial infection, conjunctivitis, eosinophilia, eyelid disorder, haemoglobin decreased. Memantine dosage: 0.25 MG BID PO. During the same period patient was treated with DICLOFENAC, FUROSEMIDE, LEVOTHYROXINE, ARICEPT, NICARDIPINE, POTASSIUM CHLORIDE, EQUANIL, IMOVANE. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #4891799-9
Memantine side effect was reported by a Consumer or non-health professional from FRANCE on Jan 11, 2006. Female patient, 81 years of age, was diagnosed with dementia alzheimer's type, pain  and was treated with Memantine. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, blood creatinine increased, blood pressure systolic increased, blood thyroid stimulating hormone increased, blood urea increased, c-reactive protein increased, chlamydial infection, conjunctivitis, cough. Memantine dosage: unknown. During the same period patient was treated with DICLOFENAC, FUROSEMIDE, LEVOTHYROXINE, ARICEPT, NICARDIPINE, POTASSIUM CHLORIDE, EQUANIL, IMOVANE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5657878-3
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on Feb 17, 2008. Male patient, 77 years of age, weighting 127.9 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, aspartate aminotransferase increased, blood urea increased, cardiac failure, cerebellar infarction, cerebral atrophy, cerebral haemorrhage, haemoglobin decreased, meningitis pneumococcal. Memantine dosage: unknown. During the same period patient was treated with ASPIRIN, AZULENE SULFONATE, CILOSTAZOL, ANTIBIOTICS, NIFEDIPINE, ETHYL ICOSAPENTATE, RILMAZAFONE HYDROCHLORIDE, WARFARIN. Patient was hospitalized and became disabled. Patient recovered.

Memantine Side Effects Report #4724496-0
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on July 08, 2005. Male patient, 74 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood pressure increased, blood urea increased, body temperature increased, cholangitis, cholecystitis, cholelithiasis, depressed level of consciousness, grip strength decreased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with SULPIRIDE, TOCOPHEROL NICOTINATE, BROTIZOLAM. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5779770-6
Memantine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 02, 2008. Male patient, 75 years of age, was diagnosed with dementia , parkinson's disease  and was treated with Memantine. After drug was administered, patient experienced the following side effects: asthenia, blood urea increased, feeling hot, flushing, paraesthesia, sinus bradycardia, spinal osteoarthritis. Memantine dosage: unknown. During the same period patient was treated with SINEMET, ATENOLOL, LISINOPRIL, SOLPADENE, STALEVO. Patient recovered.

Memantine Side Effects Report #6053173-1
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Jan 13, 2009. Male patient, 75 years of age, was diagnosed with dementia  and was treated with Memantine. After drug was administered, patient experienced the following side effects: asthenia, blood urea increased, echocardiogram abnormal, exostosis, feeling hot, flushing, glomerular filtration rate decreased, paraesthesia, sinus bradycardia. Memantine dosage: unknown. During the same period patient was treated with SINEMET, ATENOLOL, LISINOPRIL, ACETAMINOPHEN W, STALEVO. Patient recovered.


Memantine Side Effects Report #5288085-4
Memantine side effect was reported by a Health Professional from UNITED STATES on Mar 26, 2007. Male patient, 85 years of age, weighting 183.0 lb, was diagnosed with cerebral atrophy and was treated with Memantine. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, aortic dilatation, atrial fibrillation , blood urea increased, dilatation atrial, ejection fraction decreased, fall , glomerular filtration rate decreased, haematocrit decreased. Memantine dosage: 10 MG QD PO. During the same period patient was treated with DONEPEZIL, WARFARIN, SOTALOL HYDROCHLORIDE, GLYBURIDE AND METFORMIN, ACTOS, SIMVASTATIN, TERAZOSIN. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5198459-8
Memantine side effect was reported by a Health Professional from UNITED STATES on Dec 20, 2006. Male patient, 85 years of age, weighting 183.0 lb, was diagnosed with cerebral atrophy and was treated with Memantine. After drug was administered, patient experienced the following side effects: aortic dilatation, blood urea increased, breath sounds abnormal, cardiac pacemaker insertion, dilatation atrial, fall , feeling abnormal, glomerular filtration rate decreased, haematocrit decreased. Memantine dosage: 10 MG QD PO. During the same period patient was treated with DONEPEZIL, WARFARIN, SOTALOL HYDROCHLORIDE, GLYBURIDE AND METFORMIN, ACTOS, SIMVASTATIN, TERAZOSIN. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5406185-2
Memantine side effect was reported by a Physician from UNITED STATES on July 26, 2007. Male patient, 85 years of age, weighting 183.0 lb, was diagnosed with atrophy and was treated with Memantine. After drug was administered, patient experienced the following side effects: atrial fibrillation , blood pressure increased, blood urea increased, bradycardia, dilatation atrial, dizziness , fall , haematocrit decreased, haemoglobin decreased. Memantine dosage: 10 MG QD PO. During the same period patient was treated with DONEPEZIL, WARFARIN, SOTALOL HYDROCHLORIDE, GLYBURIDE AND METFORMIN, ACTOS, SIMVASTATIN, TERAZOSIN. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5466864-8
Memantine side effect was reported by a Health Professional from FRANCE on Aug 13, 2007. Male patient, 85 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: blood urea increased, cerebral atrophy, dehydration, rhabdomyolysis. Memantine dosage: 10 MG BID PO. During the same period patient was treated with GALANTAMINE HYDROBROMIDE, RISPERDAL. Patient was hospitalized. Patient recovered.